US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

31.40

+0.83382.73%

Post-market: 31.04-0.3603-1.15%19:30 EDT

Volume:2K

Turnover:61.63K

Market Cap:50.99M

PE:- -

High:31.40

Open:31.29

Low:30.96

Close:30.57

52wk High:32.99

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.13

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Argenx CEO Change Vindicated by Celiac-Disease Trial Success

Argenx's Vyvgart Trial Setback is Major Negative Surprise

Argenx Shares Plunge After Autoimmune-Disease Trial Halt

Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell

MT Newswires Live

U.S. Futures Sink, European Stocks Down

Parker Hannifin Corp. Stock Underperforms Wednesday When Compared to Competitors

Danaher call volume above normal and directionally bullish

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live

Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Wednesday

MT Newswires Live

10x Genomics, Fred Hutch Launch Clinical Research Collaboration on Single-Cell, Spatial Oncology Applications

10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers

THOMSON REUTERS

Danaher Corporation - AI-Powered Lab Expected to Operate at Scale in Early 2027

THOMSON REUTERS

Danaher Accelerates Life Sciences Research with New AI-Powered Autonomous Lab

THOMSON REUTERS

Thermo Fisher price target raised to $750 from $650 at Barclays

Danaher (DHR) Draws Fresh RBC Backing, Is The Valuation Still Compelling?

Simply Wall St.

Revvity Inc. Stock Underperforms Tuesday When Compared to Competitors

10x Genomics falls -13.4%

Quantum BioPharma signs contract with Thermo Fisher for sclerosis trial

Steris PLC Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/FMED/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":31.4003,"timestamp":1791576000000,"preClose":30.5665,"halted":0,"volume":1978,"hourTrading":{"tag":"盘后","latestPrice":31.04,"preClose":31.4003,"latestTime":"19:30 EDT","volume":2,"amount":62.8006,"timestamp":1791588604671,"change":-0.3603,"changeRate":-0.011474,"amplitude":0},"delay":0,"changeRate":0.027278229434184485,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Market Closed","change":0.8338,"latestTime":"10-09 16:00:00 EDT","open":31.29,"high":31.4003,"low":30.96,"amount":61627.157444,"amplitude":0.014405,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":30.5665,"sharesOutstanding":2323806,"nav":30.548457,"aum":49604767.767342,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.04,"preClose":31.4003,"latestTime":"19:30 EDT","volume":2,"amount":62.8006,"timestamp":1791588604671,"change":-0.3603,"changeRate":-0.011474,"amplitude":0},"volumeRatio":0.12585579250629644,"impliedVol":0.0666,"impliedVolPercentile":0.0854},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.12585579250629644,"shares":1623806,"dividePrice":0,"high":31.4003,"amplitude":0.014405,"preClose":30.5665,"low":30.96,"week52Low":23.48,"pbRate":"--","week52High":32.985,"institutionHeld":0,"latestPrice":31.4003,"eps":0,"divideRate":0,"volume":1978,"delay":0,"ttmEps":0,"open":31.29,"prevYearClose":27.05,"prevWeekClose":31.8182,"prevMonthClose":32.3871,"prevQuarterClose":32.3871,"fiveDayClose":31.8182,"twentyDayClose":31,"sixtyDayClose":28.8117},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673074881","title":"Argenx CEO Change Vindicated by Celiac-Disease Trial Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074881","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074881?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:41","pubTimestamp":1791459660,"startTime":"0","endTime":"0","summary":"1140 GMT - Argenx's positive results for a midstage clinical trial in celiac disease vindicates its CEO change earlier this year, Bernstein analysts say in a research note. The Amsterdam-based biotech company said a drug candidate it acquired through its Forte Biosciences deal, FB102, hit the goal in a study, reinforcing the potential of a medicine being tested for two diseases with little or no existing nonsystemic drug treatment options, the analysts say. \"A key rationale for the CEO transition was to diversify the organic pipeline with external innovation,\" the analysts add. Argenx separately said it would discontinue a trial for its main drug Vyvgart in Sjogren's disease. This should come as little surprise given that Sjogren's is a heterogeneous disease that has become a research-and-development \"graveyard\" for the industry, according to Bernstein. Shares fall 16%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B4R5TH58.HKD","ARGX","LU0109394709.USD","LU0889565916.HKD","IE00B2B36J28.USD","BK4505","IE00BFTCPJ56.SGD","FMED","BK4139","BK4588","IE0002141913.USD","IBB","LU0390134368.USD","LU0823416689.USD","TBXU","IE0034235188.USD","IE00BJT1NW94.SGD","LU2324357040.USD","BK4585","IE0009355771.USD","LU1983260115.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673207168","title":"Argenx's Vyvgart Trial Setback is Major Negative Surprise","url":"https://stock-news.laohu8.com/highlight/detail?id=2673207168","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673207168?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:25","pubTimestamp":1791458700,"startTime":"0","endTime":"0","summary":"1125 GMT - Argenx's decision to stop a late-stage clinical trial of its Vyvgart drug in Sjogren's disease comes as a major negative surprise for the European biotech company, UBS analysts say in a note. \"We believe Argenx's discontinuation of Sjogren's study at interim suggests potentially very little efficacy--if any--not just a 'near miss',\" the analysts say. The drug had generated positive and solid results in a midstage study, as had a similar medicine from rival Johnson & Johnson, Imaavy, they add. The study was supposed to be one of the most closely watched updates from Argenx next year, and UBS had modeled peak annual sales for Vyvgart in Sjogren's at $3.5 billion, the analysts say. Shares fall 16%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","BK4139","LU0823416689.USD","LU2324357040.USD","ARGX","IE0002141913.USD","IE0034235188.USD","IE00BFTCPJ56.SGD","FMED","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0390134368.USD","BK4588","IE0009355771.USD","LU0320765992.SGD","BK4505","LU1983260115.SGD","LU0109394709.USD","IBB","BK4585","TBXU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673073378","title":"Argenx Shares Plunge After Autoimmune-Disease Trial Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2673073378","media":"Dow Jones","labels":["EditorSelect","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673073378?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:55","pubTimestamp":1791453300,"startTime":"0","endTime":"0","summary":"Argenx shares fell sharply after the biotech company stopped a late-stage clinical trial of its Vyvgart drug due to lack of efficacy for the treatment of autoimmune condition Sjogren's disease.Shares ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"EditorSelect,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","BK4139","LU0823416689.USD","LU2324357040.USD","ARGX","IE0002141913.USD","IE0034235188.USD","IE00BFTCPJ56.SGD","FMED","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0390134368.USD","BK4588","IE0009355771.USD","LU0320765992.SGD","BK4505","LU1983260115.SGD","LU0109394709.USD","IBB","BK4585","TBXU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022772","title":"Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022772","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022772?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:38","pubTimestamp":1791448725,"startTime":"0","endTime":"0","summary":"Argenx  will discontinue a phase 3 study of efgartigimod subcutaneous in adults with moderate-to-severe Sjogren's disease after an independent data monitoring committee recommended stopping the trial for futility, the company said Thursday.The committee concluded that the study was unable to meet its primary endpoint, while safety remained consistent with efgartigimod's established profile, according to the company.Separately, Argenx said a phase 2 study of FB102 in adults with celiac disease met its primary endpoint, showing a \"statistically significant and clinically relevant\" treatment effect, compared with placebo.The observed safety profile was consistent with previous studies and the known safety profile of FB102, with no new safety signals identified. The company plans to advance FB102 into phase 3 development, it said.Sjogren's disease is a chronic, slowly progressive, inflammatory systemic autoimmune disease characterized by destruction of the exocrine glands. Celiac disease i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","LU0889565916.HKD","LU2324357040.USD","IE00B4R5TH58.HKD","ARGX","LU0320765992.SGD","LU0109394709.USD","IBB","BK4139","IE0034235188.USD","BK4505","IE0002141913.USD","IE00BJT1NW94.SGD","TBXU","FMED","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","IE00B2B36J28.USD","LU0823416689.USD","BK4585","LU0390134368.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021694","title":"U.S. Futures Sink, European Stocks Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021694","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021694?lang=en_us&edition=fundamental","pubTime":"2026-10-08 15:31","pubTimestamp":1791444660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.U.S. futures for the S&P 500 fell 0.3%, and futures for the Dow Jones Industrial Average declined 0.6%. Changes in futures don't nec","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US10Y.BOND","BK4588","IE0002141913.USD","US30Y.BOND","EPV","IE00BJT1NW94.SGD","IBB","LU0109394709.USD","FMED","LU0889565916.HKD","LU0320765992.SGD","LU1983260115.SGD","ARGX","TBXU","BK4585","BK4505","IE00B4R5TH58.HKD","US3Y.BOND","LU2324357040.USD","US5Y.BOND","US6M.BOND","IE00B2B36J28.USD","US12M.BOND","US7Y.BOND","LU0823416689.USD","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","US2Y.BOND","IE00BJJMRZ35.SGD","LU0390134368.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048630","title":"Parker Hannifin Corp. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048630","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048630?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:37","pubTimestamp":1791405420,"startTime":"0","endTime":"0","summary":"DJ Parker Hannifin Corp. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Parker Hannifin Corp.  shed 3.26% to $952.79 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.22% to 7,801.77 and Dow Jones Industrial Average  falling 0.66% to 51,179.87.The stock's fall snapped a four-day winning streak.Parker Hannifin Corp. closed 13.38% short of its 52-week high of $1,099.94, which the company reached on August 6th.The stock underperformed when compared to some of its competitors Wednesday, as Danaher Corp.  rose 1.34% to $218.49, Honeywell International Inc.  fell 2.24% to $208.11, and Eaton Corp. PLC  fell 3.09% to $431.33.Trading volume  remained 167,413 below its 50-day average volume of 618,299.Data source: Dow Jones Market Data, FactSet. Data compiled October 7, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRID","LU0823414478.USD","DHR","IE00BZ199S13.USD","LU0528227936.USD","LU0289961442.SGD","LU0061474960.USD","LU1061106388.HKD","BK4534","BK4096","FMED","LU1791710400.SGD","ZAP","LU2249611893.SGD","LU1989764664.SGD","IE00B19Z8W00.USD","LU1861219969.SGD","LU0820561909.HKD","BK4581","IE000M9KFDE8.USD","BK4602","LU0107464264.USD","LU0390134368.USD","MADE","LU0096362180.USD","IE00BD6J9T35.USD","LU2125910336.SGD","LU0823414551.USD","PH","HON","LU1791710582.SGD","POWR","LU0320765489.SGD","LU0417517546.SGD","LU0175139822.USD","BK4121","IE00B3CCJ633.GBP","IVEP","LU2244417387.USD","ETN","BK4533","LU0882574055.USD","LU2264538146.SGD","SG9999001176.USD","LU0157215616.USD","POW","LU1989772840.SGD","JOUL","HONG","ETNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673175700","title":"Danaher call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2673175700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673175700?lang=en_us&edition=fundamental","pubTime":"2026-10-08 02:45","pubTimestamp":1791398711,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Danaher (DHR) with 2,780 calls trading, 1.1x expected, and implied vol increasing almost 2 points to 42.17%. 10/9 w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/danaher-call-volume-above-normal-and-directionally-bullish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/danaher-call-volume-above-normal-and-directionally-bullish-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2125909247.SGD","SGXZ57979304.SGD","DHR","SG9999001176.USD","LU0097036916.USD","LU0114720955.EUR","LU2125910179.SGD","IE00BQXX3D17.EUR","LU0672654240.SGD","LU0122379950.USD","SG9999013999.USD","IE00BQXX3F31.USD","LU2125909593.SGD","LU1551013342.USD","LU0320765059.SGD","LU0708995401.HKD","LU1551013425.SGD","LU0943347566.SGD","LU0528227936.USD","LU0390134368.USD","LU1023059063.AUD","LU2211814178.USD","LU2265009873.SGD","SG9999004303.SGD","LU1061106388.HKD","IE00BQXX3C00.GBP","LU1057294990.SGD","LU0289961442.SGD","BK4581","LU0289960550.SGD","LU0820561818.USD","LU0820562030.AUD","LU0511384066.AUD","LU0289739343.SGD","LU0107464264.USD","LU0820561909.HKD","LU0109391861.USD","FMED","LU1791710400.SGD","LU1804176565.USD","LU1923622614.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1791710582.SGD","SG9999001176.SGD","LU2244417387.USD","BK4504","BK4121","LU0187121727.USD","LU2125910336.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301969","title":"European Equities Traded in US as ADRs Fall in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673301969?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:09","pubTimestamp":1791385793,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell late Wednesday morning with the S&P Europe Select ADR Index declining 1.2% to 1,875.05.From continental Europe, the gainers were led by medical device maker EDAP TMS  and pharmaceutical company Sanofi , which increased 3% and 0.8%, respectively. They were followed by pharmaceutical company Novo Nordisk  and biopharmaceutical company argenx , which were up 0.6% and 0.4%, respectively.The decliners from continental Europe were led by lender Banco Bilbao Vizcaya Argentaria  and biopharmaceutical company Cellectis , which decreased 3.9% and 3.6%, respectively. They were followed by lenders Banco Santander  and ING , which dropped 3.3% and 3.2%, respectively.The gainers from the UK were led by biopharmaceutical companies NuCana  and Mereo BioPharma Group , which advanced 3.8% and 3.3%, respectively. They were followed by telecommunications operator Vodafone Group  and tobacco company British American Tobacco , which ros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","BK4132","02378","LU0390134368.USD","FOCL","LU0128525689.USD","LU2324357040.USD","PUK","OZEM","00005","VOD","BK4505","BDRX","LU0154236417.USD","THNR","IE0034235188.USD","LU0320765992.SGD","HSBH","BBVA","LU0052756011.USD","LU0006061336.USD","LU0823416689.USD","FMED","LU0496365809.HKD","LU1983260115.SGD","LU1093756168.USD","BK4532","NICO","BK4139","IE00BFTCPJ56.SGD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","NVOH","BK4521","IBB","MREO","NVO","ARGX","LU0211326755.USD","BK4082","LU0310800965.SGD","LU0109394709.USD","LU1093756325.SGD","IE00BFXG1179.USD","IE00BKVL7J92.USD","TRIB","LU0162691827.USD","LU0072461881.USD","GSIB","BK4075","BTI","LU0976567544.SGD","BK4162","LU2543165471.USD","ING","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU0211326839.USD","TBXU","BK4588","CLLS","BK4207","LU2236285917.USD","BK4007","SNY","SAN","NVOX","LU1267930227.SGD","PPH","HSBC","BK4585","BK4599","NVOC","IE00BJJMRZ35.SGD","NCNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673130070","title":"Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2673130070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673130070?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:22","pubTimestamp":1791379373,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to higher pre-bell Wednesday, with the iShares Biotechnology ETF (IBB) inactive and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.4%.Danaher (DHR) stock wa","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DHR","LU2355687059.USD","BK4137","IE0004445239.USD","LABU","BK4581","LU0289960550.SGD","LU1267930730.SGD","XBI","LU2106854487.HKD","BK4121","LU0312595415.SGD","SG9999004303.SGD","IE00BKVL7J92.USD","IE00BQXX3C00.GBP","XLV","LU0689472784.USD","LU1791710582.SGD","IE00BZ1G4Q59.USD","LU0289739343.SGD","NEOG","BK4588","HCSG","LU2125910179.SGD","IBB","BK4504","LU1023059063.AUD","LU2112291526.USD","LU0528227936.USD","LU1551013425.SGD","LU0820562030.AUD","BK4533","ARWR","FMED","LU1061106388.HKD","LU0882574055.USD","BK4534","LU2265009873.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0187121727.USD","IE00BQXX3F31.USD","LU1804176565.USD","LU2125909247.SGD","LU0122379950.USD","LU0320765059.SGD","LU0114720955.EUR","DHR.AU","SG9999013999.USD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673501391","title":"10x Genomics, Fred Hutch Launch Clinical Research Collaboration on Single-Cell, Spatial Oncology Applications","url":"https://stock-news.laohu8.com/highlight/detail?id=2673501391","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673501391?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:02","pubTimestamp":1791378153,"startTime":"0","endTime":"0","summary":"10x Genomics, Fred Hutch launch clinical research collaboration on single-cell, spatial oncology applications10x Genomics launched a clinical research collaboration with Fred Hutch to extend its oncol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDLb3B2Lh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","LU0963586101.USD","BK4548","LU1861558580.USD","TXG","BK4121","BK4588","ARKG","BK4585","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673690013","title":"10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673690013","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673690013?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:00","pubTimestamp":1791378019,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA4ZG7FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861558580.USD","TXG","FMED","BK4585","LU0963586101.USD","BK4121","BK4548","ARKG","LU1861559042.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673920600","title":"Danaher Corporation - AI-Powered Lab Expected to Operate at Scale in Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673920600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673920600?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370811,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T10J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125910336.SGD","LU2106854487.HKD","LU1923622614.USD","LU0511384066.AUD","LU0432979614.USD","LU2125910179.SGD","LU0320765059.SGD","LU1551013425.SGD","LU2125909593.SGD","LU0187121727.USD","FMED","LU0107464264.USD","LU1791710582.SGD","SGXZ23171101.USD","BK4581","LU2063271972.USD","LU0820561909.HKD","SG9999004303.SGD","DHR","LU0820561818.USD","LU1804176565.USD","LU1551013342.USD","SG9999001176.SGD","LU0175139822.USD","IE00BQXX3D17.EUR","BK4585","LU0289960550.SGD","BK4588","LU1974910355.USD","LU1023059063.AUD","LU0708995401.HKD","LU0097036916.USD","LU2265009873.SGD","IE00BKVL7J92.USD","LU0943347566.SGD","IE000M9KFDE8.USD","LU0109391861.USD","LU0672654240.SGD","LU1917777945.USD","LU2355687059.USD","LU0820562030.AUD","SG9999001176.USD","IE00BQXX3C00.GBP","LU0289739343.SGD","IE0004445239.USD","LU1061106388.HKD","LU0122379950.USD","LU0157215616.USD","LU0882574055.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673920310","title":"Danaher Accelerates Life Sciences Research with New AI-Powered Autonomous Lab","url":"https://stock-news.laohu8.com/highlight/detail?id=2673920310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673920310?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370811,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T10J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DHR","LU0511384066.AUD","LU1974910355.USD","LU2063271972.USD","BK4581","LU0175139822.USD","LU0289960550.SGD","LU1267930730.SGD","LU0820561818.USD","LU1366333091.USD","SG9999004303.SGD","LU0097036916.USD","LU0820561909.HKD","IE00BKVL7J92.USD","LU2023250504.SGD","LU2244417387.USD","SG9999001176.SGD","LU0689472784.USD","LU1791710582.SGD","IE00BZ1G4Q59.USD","LU0289739343.SGD","SGXZ23171101.USD","BK4588","BK4585","LU2125910179.SGD","LU1023059063.AUD","LU0109391861.USD","LU0528227936.USD","LU1057294990.SGD","LU1791710400.SGD","LU2125910336.SGD","BK4533","SG9999001176.USD","FMED","LU1061106388.HKD","LU0882574055.USD","BK4534","IE00BQXX3D17.EUR","LU2265009873.SGD","LU0157215616.USD","LU1923621640.USD","LU1917777945.USD","LU0187121727.USD","LU0708995401.HKD","IE00BQXX3F31.USD","LU0432979614.USD","LU0122379950.USD","LU0320765059.SGD","LU0114720955.EUR","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673094788","title":"Thermo Fisher price target raised to $750 from $650 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673094788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673094788?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:15","pubTimestamp":1791368120,"startTime":"0","endTime":"0","summary":"Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher (TMO) to $750 from $650 and keeps an Overweight rating on the shares....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/thermo-fisher-price-target-raised-to-750-from-650-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/thermo-fisher-price-target-raised-to-750-from-650-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0011850046.USD","IE00B19Z8X17.USD","LU1803068623.USD","LU0029864427.USD","LU2764262908.HKD","BK4535","LU0070302665.USD","BK4121","TMED","LU1670628061.USD","IE00BFTCPJ56.SGD","BK4588","LU0048573561.USD","IE0002141913.USD","LU0096362180.USD","LU2041044095.USD","LU1720051017.SGD","LU0528227936.USD","LU2298321311.HKD","LU0128525929.USD","LU1923622614.USD","TMO","LU1854103824.USD","HRTS","LU1548497426.USD","BK4533","BK4566","BK4585","LU1153585028.USD","IE00B1BXHZ80.USD","LU2125909593.SGD","IE0034235188.USD","LU2720916845.USD","LU2089984988.USD","LU0266013472.USD","LU1064131342.USD","IE00BQXX3D17.EUR","LU2112291526.USD","LU1988902786.USD","IE00B19Z8W00.USD","IE00BJJMRZ35.SGD","IE00BQXX3C00.GBP","BK4534","LU0342679015.USD","FMED","LU0251131958.USD","LU0345770993.USD","GNMX","LU2211814178.USD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673017095","title":"Danaher (DHR) Draws Fresh RBC Backing, Is The Valuation Still Compelling?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673017095","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673017095?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:21","pubTimestamp":1791354111,"startTime":"0","endTime":"0","summary":"Danaher (DHR) is back in focus after RBC adjusted its view, keeping an outperform rating and raising its price objective, as investors reassess recent missteps, leadership changes, and mixed biotech and diagnostics momentum.\nRecent trading has been choppy for Danaher, with the share price falling 2.53% over the last day and 4.64% over the past week. However, a 13.02% 90 day share price return and 4.04% 1 year total shareholder return suggest momentum has been rebuilding after earlier setbacks...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/265621-card/1789208395171","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/265621-card/1789208395171"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danaher-dhr-draws-fresh-rbc-backing-is-the-valuation-still-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/danaher-dhr-draws-fresh-rbc-backing-is-the-valuation-still-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0672654240.SGD","LU0528227936.USD","LU0432979614.USD","LU1923621640.USD","LU0689472784.USD","LU0943347566.SGD","LU2023250504.SGD","LU1551013425.SGD","SG9999001176.USD","LU1791710582.SGD","BK4504","LU0320765059.SGD","LU0289739343.SGD","IE00BKVL7J92.USD","LU2244417387.USD","BK4581","LU1923622614.USD","SG9999001176.SGD","LU1023059063.AUD","LU2355687059.USD","LU1551013342.USD","BK4533","LU0289961442.SGD","DHR.AU","LU2125909593.SGD","LU0114720955.EUR","FMED","IE0004445239.USD","SG9999004303.SGD","LU0820561909.HKD","LU1974910355.USD","LU2265009873.SGD","LU2106854487.HKD","LU0820561818.USD","LU0187121727.USD","BK4588","LU0882574055.USD","IE00BQXX3F31.USD","LU0312595415.SGD","DHR","LU2063271972.USD","LU0175139822.USD","BK4585","LU2211814178.USD","LU1791710400.SGD","SGXZ23171101.USD","IE00BZ1G4Q59.USD","SG9999013999.USD","LU0820562030.AUD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673298065","title":"Revvity Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673298065","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673298065?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:09","pubTimestamp":1791320940,"startTime":"0","endTime":"0","summary":"DJ Revvity Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  slid 2.58% to $153.30 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.58% to 7,818.93 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.The stock's fall snapped a two-day winning streak.Revvity Inc. closed 3.15% below its 52-week high of $158.28, which the company reached on September 30th.The stock underperformed when compared to some of its competitors Tuesday, as Danaher Corp.  fell 2.53% to $215.61, IDEXX Laboratories Inc.  fell 2.21% to $515.41, and Agilent Technologies Inc.  fell 1.00% to $169.33.Trading volume  eclipsed its 50-day average volume of 1.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["A","IE00BQXX3D17.EUR","LU1721428933.USD","LU2023250504.SGD","LU0432979614.USD","LU1721429741.USD","LU0672654240.SGD","IE00BKVL7J92.USD","LU1923621640.USD","LU2063271972.USD","BK4082","LU0690374961.EUR","SG9999004303.SGD","LU0312595415.SGD","FMED","LU2211814178.USD","LU2125910179.SGD","LU0708995401.HKD","LU2355687059.USD","LU0289739343.SGD","LU0820561818.USD","LU2404859741.USD","LU0320765059.SGD","PAWZ","LU1543694498.USD","LU1061106388.HKD","LU1165135440.EUR","LU1551013342.USD","LU2089279066.USD","DHR","LU0097036916.USD","LU1804176565.USD","LU1057294990.SGD","LU0820561909.HKD","LU2092937221.SGD","LU0187121727.USD","LU2125909247.SGD","LU0943347566.SGD","LU0690374615.EUR","IDXX","LU1366333091.USD","LU1721429402.USD","LU0390134368.USD","RVTY","SGXZ57979304.SGD","IE00BQXX3F31.USD","LU2404859667.USD","BK4121","LU2125910336.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673705776","title":"10x Genomics falls -13.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673705776","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673705776?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:00","pubTimestamp":1791302417,"startTime":"0","endTime":"0","summary":"10x Genomics (TXG) is down -13.4%, or -$13.07 to $84.67. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/10x-genomics-falls-13-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/10x-genomics-falls-13-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","ARKG","TXG","LU0963586101.USD","LU1861558580.USD","LU1861559042.SGD","FMED","BK4121","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673589610","title":"Quantum BioPharma signs contract with Thermo Fisher for sclerosis trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673589610","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673589610?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:11","pubTimestamp":1791281470,"startTime":"0","endTime":"0","summary":"Quantum BioPharma (QNTM) has entered into a Study Start-Up Agreement, or SUA, with the clinical research business of Thermo Fisher (TMO) to impleme...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quantum-biopharma-signs-contract-with-thermo-fisher-for-sclerosis-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quantum-biopharma-signs-contract-with-thermo-fisher-for-sclerosis-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","LU0882574055.USD","LU2764262908.HKD","LU1670628061.USD","FMED","LU0048573561.USD","LU2298321311.HKD","LU2089984988.USD","IE00BQXX3C00.GBP","TMO","LU0266013472.USD","LU1854104046.USD","LU2764263203.CNY","BK4535","BK4534","LU0061474960.USD","LU0342679015.USD","LU2125909759.SGD","LU2360108059.USD","LU0742534661.SGD","LU2092937221.SGD","LU0070302665.USD","QNTM","HRTS","LU0345770308.USD","IE0009355771.USD","GB00BDT5M118.USD","LU0096362180.USD","LU1923622614.USD","LU2125909593.SGD","LU0122379950.USD","LU2211815571.USD","LU2468319806.SGD","BK4121","GNMX","LU1057294990.SGD","LU2433249047.HKD","LU2211814178.USD","LU1280957306.USD","LU1923622291.USD","LU0345770993.USD","LU1988902786.USD","LU0251142724.SGD","LU2720916845.USD","IE00BJT1NW94.SGD","LU0234572021.USD","LU0251131958.USD","LU2764263039.SGD","TMED","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084021","title":"Steris PLC Stock Underperforms Monday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084021","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084021?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:06","pubTimestamp":1791234360,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Underperforms Monday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  advanced 1.21% to $211.07 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.The stock's rise snapped a four-day losing streak.Steris PLC closed 21.66% below its 52-week high of $269.44, which the company reached on January 16th.The stock underperformed when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc.  rose 3.35% to $676.76, Danaher Corp.  rose 3.34% to $221.21, and Becton Dickinson & Co.  rose 2.19% to $180.67.Trading volume  eclipsed its 50-day average volume of 684,029.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072461881.USD","BK4585","IHI","LU2357305700.SGD","IE00BKVL7J92.USD","LU0345770993.USD","LU0511384066.AUD","LU1923621640.USD","LU0477156797.USD","LU0109391861.USD","LU0820561909.HKD","LU1974910355.USD","IE00B19Z8W00.USD","SGXZ23171101.USD","STE","LU2720916845.USD","LU0114720955.EUR","LU2298321311.HKD","LU1983299246.USD","LU2063271972.USD","DHR","LU0985320562.USD","TMO","HRTS","FMED","LU1791710582.SGD","LU0640476718.USD","BK4504","BDX","GNMX","LU0130518102.USD","LU0528227936.USD","LU1057294990.SGD","LU2360108059.USD","LU1366333091.USD","LU0068578508.USD","LU2125909247.SGD","LU0097036916.USD","LU0433182093.SGD","LU0708995401.HKD","LU2764263203.CNY","BK4581","LU0096362180.USD","LU1551013425.SGD","TMED","IE00BJJMRZ35.SGD","LU0557290698.USD","LU0130103400.USD","LU1548497426.USD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084910","title":"Medtronic PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084910?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:38","pubTimestamp":1791232680,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  advanced 1.84% to $87.97 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.Medtronic PLC closed 17.27% short of its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Danaher Corp.  rose 3.34% to $221.21, and Abbott Laboratories  rose 2.67% to $100.10.Trading volume  eclipsed its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","IE0004445239.USD","LU0345770308.USD","RXL","VHT","LU1674673691.USD","TMED","IHI","LU1718418525.SGD","IXJ","TRUH","MEDX","ABT","LU0314106906.USD","LU1145028129.USD","LU2125909593.SGD","IYH","LU1061106388.HKD","FHLC","IE00B3PB1722.GBP","MDT","DHR","FMED","LU2063271972.USD","LU1280957306.USD","SG9999013999.USD","IHE","GDOC","FTXH","LU0122379950.USD","LU1923622614.USD","XLV","LU1989763427.SGD","LU1003077747.HKD","LU0211326839.USD","LU0070302665.USD","BMED","SG9999001176.SGD","JNJ","SGXZ57979304.SGD","JDOC","LU1778281490.HKD","LU1983299246.USD","SG9999001176.USD","IE00BKVL7J92.USD","LU2430703095.HKD","LU0006306889.USD","LU1066051225.USD","LU0943347566.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}